CClinicalTrials.gg
CompletedNCT01462045Updated Jan 6, 2015Results posted

Efficacy Study of Mindfulness-Based Exercise for Posttraumatic Stress Disorder (PTSD)

An interventional study of Mindfulness-based exercise in Stress Disorders, Post-Traumatic, sponsored by University of New Mexico. Completed at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-06.

Sponsored by University of New Mexico · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

This study will explore the relationship between changes in plasma cortisol and symptom reduction resulting from individuals with posttraumatic stress disorder (PTSD) participating in an 8-week program of mindfulness-based stretching and breathing exercise. The investigators hypothesize that at the completion of participation in the 8-week program, exercise-induced symptom reduction will be associated with changes in cortisol levels.

Read the detailed description

This study will employ an intent-to-treat design to evaluate the relationship between exercise-induced posttraumatic stress disorder (PTSD) symptom reduction and exercise-induced changes in cortisol level. The participants consist of nurses and the intervention will be conducted at the Clinical and Translational Science Center of the University of New Mexico. The study was approved by the Human Research Protections Office of the university. Nurses who are screened positively for PTSD will be randomly assigned to either control or exercise group. At baseline and in weeks 4, 8, 12 and 16, immediately after the phlebotomy for serum cortisol, the investigators will ask the participants to rate the severity of their PTSD symptoms using the PTSD Checklist (PCL).

02

Conditions studied

  • Stress Disorders, Post-Traumatic

Keywords

  • Exercise
  • Stress
  • PTSD
  • Mindfulness
  • Breathing
  • Cortisol
03

In context

Stress Disorders, Traumatic

1,148 studies on the registry are indexed under Stress Disorders, Traumatic; 108 are open to participants now.

This study's enrollment of 29 is below the median of 60 across 909 interventional studies indexed under Stress Disorders, Traumatic.

Browse Stress Disorders, Traumatic studies →

Lead sponsor

University of New Mexico is the lead sponsor of 306 studies on the registry; 28 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 23 (92%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • employed as a nurse
  • PCL-C score of at least 28 with at least a score of 3 on one or more items for inclusion in the PTSD symptomatic groups (EX and CON)
  • PCL-C score of 27 or lower for inclusion in the non-PTSD symptomatic group (BASE).

Exclusion criteria

Exclusion Criteria:

  • the inability to complete the exercise program
  • a positive answer to any of the seven screening questions on the Physical Activity Readiness Questionnaire (PAR-Q)
  • current use of prednisone or other forms of cortisone medication excluding cortisone in inhaled form
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
29 participants (actual)

Study arms

  • Experimental
    Exercise Group

    Participants who are screened positive for PTSD and participate in the series of 16 standardized, semiweekly 60-minute mindfulness-based exercise sessions. The intervention consists of stretching and balancing movements combined with breathing and a focus on mindfulness.Over the course of 8 weeks, the intensity of the exercise increases, but the sequence of the movements is the same.

    Behavioral: Mindfulness-based exercise

  • No intervention
    Control Group

    Participants who are screened positive for PTSD but do not participate in the mindfulness-based exercise.

  • No intervention
    Base Group

    Healthy volunteers who are not screened positive for PTSD and do not participate in the mindfulness-based exercise.

Interventions

  • BehavioralMindfulness-based exercise

    8-week program of mindfulness-based stretching and breathing exercises

    Also known as: Mindfulness stretching and breathing exercises

06

What researchers measure

Primary outcomes

  1. Change From Baseline in PTSD Checklist - Civilian Version (PCL-C) Score

    The PCL-C is a 17-item self-report instrument that measures the symptoms of PTSD. A total score, ranging from 17 to 85, is found by summing the scores of the 17 items. Higher values are considered to be a worse outcome. The inclusion criteria in the PTSD symptomatic group is a PCL-C total score of at least 28 with a score of 3 or higher on 1 or more items.To detect a reduction in PTSD symptom severity with a 2-sided 5% significance level and a power of 80%, the mean difference of PCL-C scores of 5.16 or greater requires a sample size of 20 participants for Exercise and Control groups, given an anticipated dropout rate of 10%. Data analyses are conducted using an a priori intention-to-treat approach. The analysis for the between-group differences of the intervention is conducted using t-tests comparing Exercise and Control groups at post-intervention. The analysis for the within-group difference is conducted using repeated measures ANOVA for both groups at baseline and week 8.

    Time frame: Baseline and 8 weeks

Secondary outcomes

  1. Cortisol

    Change from baseline in serum cortisol levels at 8 weeks. Serum cortisol samples were collected at 8:00 Ante Meridian (AM). The changes are calculated from two time points as the values at 8 weeks minus the values at baseline.

    Time frame: baseline and 8 weeks

07

Results

Posted Dec 15, 2014

Participant flow

Nurse volunteers were recruited from the University of New Mexico Hospital through advertisement,between September 1, 2011 and March 31, 2012.

Participant flow — Overall Study
MilestoneExercise GroupControl GroupBase Group
Started11117
Completed11107
Not completed010
Withdrew: Family matter010

Outcome measures

PrimaryChange From Baseline in PTSD Checklist - Civilian Version (PCL-C) Score

The PCL-C is a 17-item self-report instrument that measures the symptoms of PTSD. A total score, ranging from 17 to 85, is found by summing the scores of the 17 items. Higher values are considered to be a worse outcome. The inclusion criteria in the PTSD symptomatic group is a PCL-C total score of at least 28 with a score of 3 or higher on 1 or more items.To detect a reduction in PTSD symptom severity with a 2-sided 5% significance level and a power of 80%, the mean difference of PCL-C scores of 5.16 or greater requires a sample size of 20 participants for Exercise and Control groups, given an anticipated dropout rate of 10%. Data analyses are conducted using an a priori intention-to-treat approach. The analysis for the between-group differences of the intervention is conducted using t-tests comparing Exercise and Control groups at post-intervention. The analysis for the within-group difference is conducted using repeated measures ANOVA for both groups at baseline and week 8.

Time frame:
Baseline and 8 weeks
Reported as:
Mean · scores on a scale
Change From Baseline in PTSD Checklist - Civilian Version (PCL-C) Score
scores on a scaleExercise GroupControl GroupBase Group
Change From Baseline in PTSD Checklist - Civilian Version (PCL-C) Score-18.8 ± 10.6-5.2 ± 15.821.8 ± 3.4
Statistical analysis
  • Exercise Group vs Control Group · t-test, 2 sided · p = <0.01 · Mean difference (final values): -13.6 · 95% CI -25.6 to -1.6
SecondaryCortisol

Change from baseline in serum cortisol levels at 8 weeks. Serum cortisol samples were collected at 8:00 Ante Meridian (AM). The changes are calculated from two time points as the values at 8 weeks minus the values at baseline.

Time frame:
baseline and 8 weeks
Reported as:
Mean · μg/dl
Cortisol
μg/dlExercise GroupControl GroupBase Group
Cortisol5.1 ± 4.5-0.7 ± 6.5-0.04 ± 9.4
Statistical analysis
  • Exercise Group vs Control Group · t-test, 2 sided · p = <0.01 · Mean difference (final values): 5.8 · 95% CI 0.83 to 10.8

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Exercise Group—0/11 (0%)0/11 (0%)
Control Group—0/11 (0%)0/11 (0%)
Base Group—0/7 (0%)0/7 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Exercise GroupControl GroupBase GroupTotal
<=18 years0000
Between 18 and 65 years1111628
>=65 years0011
Age, Continuous
Age, Continuous(years)Exercise GroupControl GroupBase GroupTotal
Mean49 ± 6.445 ± 9.944 ± 15.146 ± 10.1
Sex: Female, Male
Sex: Female, Male(Participants)Exercise GroupControl GroupBase GroupTotal
Female1011728
Male1001
Region of Enrollment
Region of Enrollment(participants)Exercise GroupControl GroupBase GroupTotal
United States1111729
08

Study locations

1 site
  • The University of New Mexico
    Albuquerque, New Mexico 87131, United States
09

References and documents

Publications

  • Kim SH, Schneider SM, Bevans M, Kravitz L, Mermier C, Qualls C, Burge MR. PTSD symptom reduction with mindfulness-based stretching and deep breathing exercise: randomized controlled clinical trial of efficacy. J Clin Endocrinol Metab. 2013 Jul;98(7):2984-92. doi: 10.1210/jc.2012-3742. Epub 2013 May 29. PubMed 23720785 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01462045
Lead sponsor
University of New Mexico
Responsible party
Sponsor
First posted
Oct 28, 2011
Start date
Oct 2011
Primary completion
Jul 2012
Completion
Oct 2012
Results posted
Dec 15, 2014
Last update
Jan 6, 2015

Study contacts

Mark R Burge, MD
principal investigator · University of New Mexico

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion